AB044. P-12. Phase 1 study of hepatic arterial infusion (HAI) therapy with floxuridine (FUDR) combined with systemic gemcitabine and oxaliplatin in patients with locally advanced intrahepatic cholangiocarcinoma (ICC)

BACKGROUND: The standard of care for unresectable intrahepatic cholangiocarcinoma (ICC) is palliative systemic chemotherapy with cisplatin and gemcitabine. The use of hepatic arterial infusion (HAI) floxuridine (FUDR) with systemic chemotherapy may improve outcomes. We conducted a phase 1 study of H...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepatobiliary Surg Nutr
Autors principals: Grierson, Patrick, Oza, Aabha, Doyle, Maria, Fields, Ryan, Hawkins, William, Hammill, Chet, Wang-Gillam, Andrea, Amin, Manik, Pedersen, Katrina, Lim, Kian-Huat, Morton, Ashley, Cordova, Christine, Fowler, Kathryn, Tan, Benjamin, Chapman, William
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2019
Matèries:
Poster Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6421181/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB044
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars